海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Mesylate tablets of apatinib as first-line treatment of metastatic soft tissue sarcoma, randomized, crossover, multi center clinical study
- metastatic soft tissue sarcoma
- China
- 2018-07-30
Recruiting
- Effect of oral MgSo4 administration on plasma ox-LDL, LOX-1 and lipid profiles in atherosclerosis patients
- Patients with high blood pressure and Hyperlipidemic with a small plaque in one of the coronary arteries. Atherosclerotic heart disease of native coronary artery without angina pectoris;I25.10
- Iran (Islamic Republic of)
- 2018-07-28
Recruiting
- A Study to Evaluate SHR-1210 in Combination With FOLFOX4 Regimen as First-Line Therapy in Subjects With Advanced HCC
- Advanced Hepatocellular Carcinoma
- China
- 2018-07-22
Recruiting
- Jiedu Granule in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- Hepatocellular carcinoma
- China
- 2018-07-16
Not recruiting
- A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations
- NSCLC
- China
- 2018-07-12
Recruiting
- Huaier Granule in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- Hepatocellular carcinoma
- China
- 2018-07-11
Not Recruiting
- A Phase II Clinical Study of Chidamide as Maintenance Therapy in Responding Patients With Peripheral T-cell Lymphoma Treated With First-Line Chemotherapy
- Peripheral T-cell Lymphoma
- China
- 2018-07-10
Recruiting
- Evaluation of Third-line cART Regimen in Cambodia (3DICAM)
- HIV/AIDS
- Cambodia
- 2018-07-06
Not Recruiting
- A single-arm exploratory Clinical study of Apatinib combination with SOX as First line treatment in patients with advanced gastric cancer
- Advanced gastric cancer or adenocarcinoma of the esophageal junction of the stomach
- China
- 2018-07-03
Recruiting
- A multicenter controlled phase II clinical study on oral administration of amlotinib after first-line treatment of ovarian cancer
- Ovarian cancer
- China
- 2018-07-02
Recruiting
- A randomized controlled study for the treatment of advanced hepatocellular carcinoma with anrotinib hydrochloride capsule alone or in combination with the first-line treatment with sergio
- Heaptocellular Carcinoma,HCC
- China
- 2019-03-26
Not Recruiting
- Exploratory Observational Study for Anlotinib Hydrochloride Combined with Sindilimab Second-line Therapy for Advanced Biliary System Tumor
- Advanced Biliary Tumors
- China
- 2019-03-20
Recruiting
- First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study
- Esophageal Neoplasms
- China
- 2019-03-18
Not Recruiting
- A randomized, open, parallel controlled, multicenter phase II trial of apatinib mesylate for maintenance therapy of stage III-IV epithelial ovarian cancer after first-line treatment with complete or partial remission
- epithelial ovarian cancer
- China
- 2019-03-15
Recruiting
- Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients
- Non Small Cell Lung Cancer
- China
- 2019-03-12
Not Recruiting
- Phase II clinical study for anlotinib combined with radiotherapy for second-line and above chemotherapy failed extensive stage small cell lung cancer
- small cell lung cancer
- China
- 2019-03-11
Not recruiting
- Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
- Metastatic Breast Cancer
- China
- 2019-03-11
Not recruiting
- GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients
- Pancreatic Cancer;Chemotherapy Effect;Chemotherapeutic Toxicity
- China
- 2019-03-08
Not Recruiting
- To assess the Gingival display and Gingival Zenith position display in anterior and premolar region of upper jaw and associate them with two different smile lines in both males and females.
- Periodontally and systemically healthy males and females
- India
- 2019-02-26
Recruiting
- evaluation the effect of botulinum toxin type A for treating frown lines
- skin rejuvenation.
- Iran (Islamic Republic of)
- 2019-01-30